- Home
- BBNX vs BXMX Comparison
BBNX vs BXMX Comparison
Compare BBNX & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | BXMX |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBNX | BXMX |
|---|---|---|
| Price | $29.73 | $14.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $28.09 | N/A |
| AVG Volume (30 Days) | ★ 672.2K | 205.6K |
| Earning Date | 10-28-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,570,000.00 | N/A |
| Revenue This Year | $52.13 | N/A |
| Revenue Next Year | $36.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.01 | N/A |
| 52 Week Low | $8.89 | $11.75 |
| 52 Week High | $32.71 | $13.75 |
Technical Indicators
Market Signals| Indicator | BBNX | BXMX |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 41.05 |
| Support Level | $28.00 | $14.42 |
| Resistance Level | $30.50 | $14.57 |
| Average True Range (ATR) | 1.82 | 0.17 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 38.33 | 57.43 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.